Latest News

BioNTech’s decision follows a comprehensive strategic review aimed at aligning the company’s manufacturing capacity with its clinical pipeline and long-term business direction

This setback follows Brinsupri’s unsuccessful phase 2 trial for chronic rhinosinusitis without nasal polyps, which also failed to meet its primary and secondary endpoints at both tested doses.

Exhibitions & Trade Services India Private Limited (ETSIPL) will manage the event’s organization and execution.

The two companies began collaborating in 2024 through an option and license agreement valued at up to USD 465 million, which granted Gilead access to Tubulis’ proprietary ADC platforms.

Three Moscow hospitals tested the system and achieved strong results: the algorithm identified quality problems with 94% accuracy and detected data errors in 99% of cases.

The plan itself serves as a practical guide for improving Ghana’s health defenses across multiple fronts, from enhancing laboratory capabilities to strengthening border health measures.

Foundayo (orforglipron) is the first once-daily oral GLP-1 approved for weight management with no restrictions on food, water, or timing.

McKinsey predicts that healthcare spending will rise from USD 11.2 trillion today to USD 20.5 trillion by 2050, owing primarily to the nearly doubling of the population over the age of 65.

The work centres on magnetic resonance imaging (MRI), a widely used diagnostic tool that allows doctors to visualise tumours inside the body.

It can store more than 100,000 cord blood samples and up to 5 million biological samples, creating a rich, diverse resource for medical research and clinical applications.